Nicholas Investment Partners, LP Ascendis Pharma A/S Transaction History

Nicholas Investment Partners, LP

$900 Million
Q3 2024

A detailed history of Nicholas Investment Partners, LP transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Nicholas Investment Partners, LP holds 8,474 shares of ASND stock, worth $1.07 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

8,474

Previous 23,216 63.5%

Holding current value

$1.07 Million

Previous $3.17 Million 60.04%

% of portfolio

0.14%

Previous 0.37%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$113.0 - $153.43 $1.67 Million - $2.26 Million	-14,742 Reduced 63.5%	8,474 $1.27 Million
Q2 2024 Aug 07, 2024	BUY	$121.07 - $153.67 $633,438 - $804,001	5,232 Added 29.09%	23,216 $3.17 Million
Q1 2024 May 13, 2024	BUY	$123.45 - $159.4 $1.69 Million - $2.19 Million	13,717 Added 321.47%	17,984 $2.72 Million
Q4 2023 Feb 07, 2024	SELL	$86.1 - $127.36 $14.3 Million - $21.2 Million	-166,342 Reduced 97.5%	4,267 $537,000
Q2 2023 Aug 09, 2023	SELL	$69.96 - $97.84 $5.65 Million - $7.9 Million	-80,778 Reduced 32.13%	170,609 $15.2 Million
Q1 2023 May 11, 2023	BUY	$104.9 - $126.78 $8.96 Million - $10.8 Million	85,450 Added 51.5%	251,387 $27 Million
Q4 2022 Feb 10, 2023	BUY	$99.42 - $131.97 $2.82 Million - $3.75 Million	28,383 Added 20.63%	165,937 $20.3 Million
Q3 2022 Nov 14, 2022	BUY	$84.03 - $110.23 $2.57 Million - $3.38 Million	30,623 Added 28.64%	137,554 $14.2 Million
Q2 2022 Aug 10, 2022	SELL	$78.08 - $117.61 $6.28 Million - $9.46 Million	-80,470 Reduced 42.94%	106,931 $9.94 Million
Q1 2022 May 10, 2022	BUY	$102.18 - $135.75 $7.69 Million - $10.2 Million	75,279 Added 67.14%	187,401 $22 Million
Q4 2021 Feb 14, 2022	BUY	$127.1 - $169.66 $10.8 Million - $14.4 Million	84,988 Added 313.22%	112,122 $15.1 Million
Q3 2021 Nov 15, 2021	BUY	$112.67 - $176.92 $3.06 Million - $4.8 Million	27,134 New	27,134 $4.33 Million
Q2 2019 Aug 09, 2019	SELL	$107.11 - $132.09 $497,311 - $613,293	-4,643 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$62.15 - $129.99 $288,562 - $603,543	4,643 New	4,643 $546,000

Others Institutions Holding ASND

# of Institutions

243

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.06B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.

Account

Nicholas Investment Partners, LP Ascendis Pharma A/S Transaction History